Study Evaluating the Etiology of Intra-Abdominal Infections

Intra-abdominal Infection Clinical Trial

Official title:

Study of the Etiology of Intra-Abdominal Infections

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00244088
• Other study ID #: 101316
• Status: Completed
• Phase: N/A
• First received: October 21, 2005
• Last updated: August 31, 2009
• Start date: April 2004
• Est. completion date: December 2004

Study information

• Verified date: August 2009
• Source: Wyeth is now a wholly owned subsidiary of Pfizer
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific enterococcal antimicrobial coverage.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 340
• Est. completion date: December 2004
• Est. primary completion date: December 2004
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• A case will be defined as an intra-abdominal abscess or peritoneal fluid culture that will be positive for enterococcus or an enterococcal bacteriemia in association with an intra-abdominal source of infection.

• A control will be defined as a culture-positive intra-abdominal infection or bacteriemia due to an intraabdominal focus where enterococci have not been isolated.

Exclusion Criteria:

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Intra-abdominal Infection
• Intraabdominal Infections

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Wyeth is now a wholly owned subsidiary of Pfizer